MolNFT v1 · #61144 · protein
Crystal structure of human PIM1 kinase complexed with 4-(4- hydroxy-3-methyl-phenyl)-6-phenylpyrimidin-2(1H)-one
3DCV · Proto-oncogene SERINE/THREONINE-protein kinase pim-1: “Crystal structure of human PIM1 kinase complexed with 4-(4…”. X-ray diffraction, 1 ligand (55E), 1 pocket (best druggability 0.67). MolNFT v1 #61144 on GenesisL1: 3D structure…
- PDB
- 3DCV
- Type
- protein
- Length
- 274 residues
- Chains
- 1
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Proto-oncogene SERINE/THREONINE-protein kinase pim-1
- EC
- 2.7.11.1
- UniProt
- P11309
- Ligands
- 55E
- Pockets
- 1 · best druggability 0.67
Structure
x-ray diffraction · 1 distinct chain · 37% helix, 23% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Proto-oncogene SERINE/THREONINE-protein kinase pim-1 (EC 2.7.11.1) | protein | 274 | 37% helix, 23% strand | P11309 |
Ligands and binding sites
- 55E · 4-(4-hydroxy-3-methylphenyl)-6-phenylpyrimidin-2(5H)-one · ligand · chains A
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 296 | 0.67 | 0.82 | 40 | 55E |
Modifications
Observed in the structure: 1 modified (phosphorylation).
Compared structures
- 3DCV · Crystal structure of human Pim1 kinase complexed with… · the same entry in another collection · chain A against A, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt P11309
- Elsewhere: RCSB PDB 3DCV · PDBe 3DCV · UniProt P11309
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.